483
Pharbest Pharmaceuticals, Inc.FDA 483 - Pharbest Pharmaceuticals, Inc. - November 10, 2022
Record Details
Pharbest Pharmaceuticals, Inc. in Farmingdale, NY, a human drug manufacturer, was inspected and received a Form 483 with seven observations. The inspection revealed significant deficiencies in data integrity, stability testing, investigation procedures, cleaning validation, equipment qualification, and routine equipment checks, indicating a broad lack of adherence to cGMP requirements.
Open in Dashboard
ID · 96bc3ad9-e1df-4616-97bc-648432ec8736